PPT-Atrial Fibrillation Who is at risk for atrial fibrillation?

lt1 of individuals aged 60 to 65 years 8 to 10 of individuals aged gt80 years Men more than women White persons more than black persons Presence and severity of underlying heart disease increases risk . Date. Jaret Tyler, MD. Clinical Cardiac Electrophysiologist. Assistant Professor of Medicine. Ohio State’s Heart and Vascular Center. Atrial Fibrillation:. How Your “Type” Affects Your Treatment. Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. Journal Club . October 21,2015. Kathleen McNamara, . PharmD. Stroke Risk Calculation. Which tool do you most typically use to evaluate stroke . risk for patients with a fib? . CHADS2 score. CHADS2-VASc. Amit Kishore. Consultant and Honorary Senior Lecturer . in Stroke Medicine , . SRFT. Amit.Kishore@srft.nhs.uk . January 2017. Cryptogenic strokes. ‘. Brain infarction . that is not attributable to a source of definite . Rhea C. Pimentel, MD. Associate Professor of Medicine. Fellowship Program Director, Clinical Cardiac Electrophysiology Program. Disclosures. Speakers Bureau: Medtronic. Speakers Bureau: St. Jude Medical. Martha Drake MS, FNP-BC. Chicago Heart and Vascular Consultants, LTD. Purdue Northwest Doctorate of Nursing Program. Learning Objectives. Discuss the incidence of atrial fibrillation (AF) in the population. A . CASE SERIES AND REVIEW OF THE LITERATURE . 1. Lily . K. . Fatula. , BS; . 1,2. William . D. Bolton, MD; . 1,2. Barry . R. Davis, MD; . 1,2. James . E. Stephenson, MD; . 1,2. Sharon . Ben-Or, MD. . Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. A . CASE SERIES AND REVIEW OF THE LITERATURE . 1. Lily . K. . Fatula. , BS; . 1,2. William . D. Bolton, MD; . 1,2. Barry . R. Davis, MD; . 1,2. James . E. Stephenson, MD; . 1,2. Sharon . Ben-Or, MD. . CLINICAL associate professor,. New york . medical college.. Objectives. Introduction & Definitions. Epidemiology and Risk Factors. Classification of Atrial Fibrillation. Evaluation & Diagnostics. Amir Shaikh, MD; David D McManus, . MD,ScM. Assistant Professor,. Department of Medicine. University of Massachusetts Medical School, Worcester, MA, USA. Disclosures. David D McManus, MD, . ScM. has received research funding from: . Maclennan D, Bartlett S, Cassels A, McBain I, Tompkins K, . Mcauley. S, . Cvoro. V; Ward 42, Victoria Hospital, Hayfield road, Kirkcaldy, KY2 5AH. David MacLennan. NHS Lothian/Fife. South East Scotland Deanery. Maclennan D, Bartlett S, Cassels A, McBain I, Tompkins K, . Mcauley. S, . Cvoro. V; Ward 42, Victoria Hospital, Hayfield road, Kirkcaldy, KY2 5AH e-mail: david.maclennan@nhslothian.scot.nhs.uk. abstract.  Have your sayWe would welcome your comments to help us produce the best information for you. Why not let us k